Activations in vivo

Rifamycia B is not biologically active but is spontaneously converted in aqueous solution to the active rifamycias O, S, and SV. Rifamycia SV was chosen for further studies because of its good in vivo activity, low toxicity, and solubiUty properties. Rifamycia SV is effective against a variety of infections as well as being active against tuberculosis and leprosy (168). Rifamycia P is the most active of the naturally occurring rifamycias (174). [Pg.499]

J) At position 1, an acidic side chain two or three carbons long should be present. The natural L-alanyl side chain reduces receptor binding but enhances in vivo activity by increasing access to the receptor and by retarding metaboHsm and excretion. The enantiomeric D-analogues retain considerable activity in contrast to other bioactive substances (17). [Pg.50]

Since the discovery of SQ 83,360, compounds such as U-78,608 [123444-35-9] (64) having different linker groups between the hydroxypytidone group and the sulfonyl residue have been reported. U-78,608 and SQ 83,360 have similar in vitro and in vivo activity (45). [Pg.69]

The configuration at the chiral centers C-4a, C-5a, and C-12a determine the conformation of the molecule. In order to retain optimum in vitro and in vivo activity, these centers must retain the natural configuration. The hydrophobic part of the molecule from C-5 to C-9 is open to modification ia many ways without losing antibacterial activity. However, modification at C-9 may be critical because steric iateractions or hydrogen bonding with the oxygen atom at C-10 may be detrimental to the activity. [Pg.179]

Because of the increasing emphasis on monitoring of environmental cadmium the detemiination of extremely low concentrations of cadmium ion has been developed. Table 2 Hsts the most prevalent analytical techniques and the detection limits. In general, for soluble cadmium species, atomic absorption is the method of choice for detection of very low concentrations. Mobile prompt gamma in vivo activation analysis has been developed for the nondestmctive sampling of cadmium in biological samples (18). [Pg.393]

An antimicrobial soap is a soap containing an active ingredient with both in vitro and in vivo activity against skin microorganisms. [Pg.140]

Investigation of the differences in crystal packing between (431) and (426) from comparison of their respective X-ray structures, revealed that (431) was more tightly packed than (442), reflected in their respective melting points of 235 and 170 °C. It was postulated that the absence of in vivo activity for (431) may be explained by the resultant reduction in water solubility and dissolution rate compared with (426). The comparatively high calculated polar surface area of (431) (122.5A ) compared with (426) (89.3 A ) was also proposed as a factor influencing the marked difference in bioavailability between the two related compounds. Compound (426) (SLV-319) is currently being developed with Bristol-Myers Squibb for the potential treatment of obesity and other metabolic disorders. Phase I trials for obesity were started in April 2004. Earlier Phase I clinical trials for the treatment of schizophrenia and psychosis, which commenced in April 2002, appear to have been abandoned. [Pg.285]

A lead is variously defined in the pharmaceutical industry as a compound derived from a hit with some degree of in vitro optimization (potency in primary assay, activity in functional and/or cellular assay), optimization of physical properties (solubility, permeability), and optimization of in vitro ADME properties (microsomal stability, CYP inhibition). Moreover, a lead must have established SAR/SPR around these parameters such that continued optimization appears possible. A lead may also have preliminary PK and in vivo animal model data. However, it is the task of the lead optimization chemist to improve PK and in vivo activity to the levels needed for identification of a clinical candidate. [Pg.178]

Proudfoot AE, Handel TM, Johnson Z, et al. Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines. Proc Natl Acad Sci U S A 2003 100 1885-90. [Pg.29]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...